Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

C

Currax Pharmaceuticals

Pharma

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

4

Clinical Trials↗

All sponsored trials (all statuses)

16

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Sep 1, 2026FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Jul 16, 2026FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Aug 6, 2025FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Aug 27, 2024FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Aug 27, 2024FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Jul 23, 2024FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Jan 3, 2024TrialEffect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

Sep 22, 2023FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

2 more events

Aug 21, 2023FDADoxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Nov 2, 2017TrialStudy to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

4 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Doxepin Hydrochloride9 patentsMay 18, 2027 Doxepin Hydrochloride5 patentsJan 18, 2028 Doxepin HydrochlorideJun 1, 2029 Doxepin HydrochlorideSep 7, 2030

Regulatory

Regulatory Timeline

20204 events

FDAOct 29

Doxepin Hydrochloride — SILENOR

Application NDA022036

FDAOct 16

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA210675

FDASep 4

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA210268

FDAJul 28

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA213474

20213 events

FDAApr 21

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA215076

FDAApr 1

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA214908

FDAMar 1

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA211618

20222 events

FDAJun 24

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA215113

FDAFeb 9

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA215710

20235 events

FDASep 22

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA202510

FDAAug 21

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA217975

FDAAug 16

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA212357

FDAApr 3

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA214823

FDAFeb 17

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA215408

20243 events

FDAAug 27

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA210675

FDAAug 27

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA210675

FDAJul 23

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA207482

20251 event

FDAAug 6

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA219058

20262 events

FDASep 1

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA211619

FDAJul 16

Doxepin Hydrochloride — DOXEPIN HYDROCHLORIDE

Application ANDA070791

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)